The First Affiliated Hospital of Baotou Medical College

Baotou, Inner Mongolia 14017

2 studies enrolling now · 8 studies all time

What they study most

Active Nonsegmental Vitiligo, Acute Non-cardioembolic Ischemic Stroke, Asthma, Atrial Fibrillation, Chronic Cutaneous Lupus Erythematosus, High-risk Transient Ischemic Attack, Kidney Disease, Non-diabetic Chronic Kidney Disease, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism, Primary Membranous Nephropathy, Stable Nonsegmental Vitiligo

Studies at this site

• A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma — Recruiting now
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy — Running, not enrolling
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early